FDA Adverse Event Malfunction Summary report: N

MYNX CADENCE VASCULAR CLOSURE DEVICE 5F

MDR report key: 3191913 · Received June 27, 2013

Report

Report Number
3004939290-2013-00155
Event Type
Malfunction
Date Received
June 27, 2013
Date of Event
April 9, 2013
Report Date
May 29, 2013
Manufacturer
ACCESSCLOSURE, INC.
Product Code
MGB
PMA / PMN Number
P040044
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
RISK MANAGER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED; THEREFORE, A PHYSICAL INVESTIGATION COULD NOT BE PERFORMED. BASED ON THE INFORMATION PROVIDED AND NO RETURNED DEVICE FOR PHYSICAL INVESTIGATION, THE REPORTED EVENT COULD NOT BE CONFIRMED AND THE ROOT CAUSE COULD NOT BE DETERMINED. THE REVIEW OF THE LHR (LOT F1233802) INDICATED THAT THE DEVICE LOT MET ALL ESTABLISHED PERFORMANCE CRITERIA PRIOR TO SHIPMENT.

Description of Event or Problem · 1

ON (B)(6) 2013, ACI RECEIVED A COPY OF A MEDWATCH REPORT (B)(4), WHICH WAS SUBMITTED TO THE FDA BY THE USER FACILITY. THE REPORT STATED THAT THE DATE OF EVENT WAS (B)(6) 2013 AND THE DATE OF THE REPORT WAS (B)(6) 2013. THE FOLLOWING INFORMATION IS THE DESCRIPTION OF THE COMPLAINT/EVENT NOTED IN THE MEDWATCH REPORT: "DURING PREPARATION FOR DEPLOYMENT IT WAS NOTED THAT A SMALL AMOUNT OF COLLAGEN WAS ALREADY OUTSIDE OF THE PRODUCT HOUSING." THE ACI SALES PROFESSIONAL REPORTED ON (B)(6) 2013 THAT THE MANAGER OF THE SPECIALS DEPARTMENT INFORMED HIM THAT FOLLOWING A PERIPHERAL CATHETERIZATION PROCEDURE THE PHYSICIAN SELECTED A MYNX CADENCE VASCULAR CLOSURE DEVICE 5F FOR CLOSURE. WHEN THE STAFF OPENED THE DEVICE FROM THE PACKAGING, THE SEALANT WAS "DANGLING LOOSE ON THE WIRE OUTSIDE OF THE SEALANT SLEEVE OF THE DELIVERY SYSTEM". THE DEVICE WAS NOT USED. IT IS UNKNOWN HOW HEMOSTASIS WAS ACHIEVED. NO FURTHER INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
293731 MYNX CADENCE VASCULAR CLOSURE DEVICE 5F MGB MGB ACCESSCLOSURE, INC. MX5001 F1233802

Patients

Seq Age Sex Outcome Treatment
1 68 YR